APA (7th ed.) Citation

Zeng, T., Zeng, T., Pan, Y., Yuan, Z., Chen, D., Song, Y., . . . Gao, Y. (2022, September). Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma. Frontiers in Immunology.

Chicago Style (17th ed.) Citation

Zeng, Tian-mei, Tian-mei Zeng, Yu-fei Pan, Zhen-gang Yuan, Dong-sheng Chen, Yun-jie Song, Yong Gao, and Yong Gao. "Immune-related RNA Signature Predicts Outcome of PD-1 Inhibitor-combined GEMCIS Therapy in Advanced Intrahepatic Cholangiocarcinoma." Frontiers in Immunology Sep. 2022.

MLA (9th ed.) Citation

Zeng, Tian-mei, et al. "Immune-related RNA Signature Predicts Outcome of PD-1 Inhibitor-combined GEMCIS Therapy in Advanced Intrahepatic Cholangiocarcinoma." Frontiers in Immunology, Sep. 2022.